We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACUT market cap is 2.5M. The company's latest EPS is USD -0.1808 and P/E is -1.22.
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -670k | -3.75M | -2.05M |
Net Income | -670k | -3.75M | -2.05M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.35M | 940k | 134k |
Total Liabilities | 703k | 1.08M | 2.25M |
Total Equity | 650k | -140k | -2.11M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | -1.81M | -1.62M |
Investing | N/A | -11k | N/A |
Financing | N/A | 2.55M | 903k |
Market Cap | 2.5M |
Price to Earnings Ratio | -1.22 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 115.79 |
Price to Book Ratio | -1.18 |
Dividend Yield | - |
Shares Outstanding | 11.35M |
Average Volume (1 week) | 2.28k |
Average Volume (1 Month) | 6.47k |
52 Week Change | -64.86% |
52 Week High | 0.7246 |
52 Week Low | 0.22 |
Spread (Intraday) | 0.17 (43.12%) |
Company Name | Accustem Sciences Inc (QB) |
Address |
300 creek view road suite 209 newark, delaware 19711 |
Website | https://www.accustem.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions